DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Preliminary Experience of Routine Voriconazole Therapeutic Drug Monitoring (TDM) in a Tertiary Care Centre

Information source: Universitaire Ziekenhuizen Leuven
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Patients Treated With Voriconazole

Phase: N/A

Status: Completed

Sponsored by: Universitaire Ziekenhuizen Leuven

Official(s) and/or principal investigator(s):
Kim Vanstraelen, R.Ph., Principal Investigator, Affiliation: Catholic University of Leuven, Faculty of Pharmacy, division Hospital Pharmacy

Summary

The first goal of this study is to map all the subtherapeutic, therapeutic and supratherapeutic voriconazole plasma levels in the University Hospitals Leuven. The second objective is to optimize and validate guidelines for dose modifications in patients with too low or high plasma concentrations and to investigate if the same guidelines can be used in different patient populations.

Clinical Details

Official title: Preliminary Experience of Routine Voriconazole Therapeutic Drug Monitoring (TDM) in a Tertiary Care Centre.

Study design: Observational Model: Case-Only, Time Perspective: Prospective

Primary outcome: Voriconazole plasma levels during routine intravenous and oral therapy

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Patients treated with voriconazole

- at least 1 voriconazole plasma level measured during therapy

Exclusion Criteria:

- none

Locations and Contacts

University Hospitals Leuven, Leuven, Vlaams-Brabant 3000, Belgium
Additional Information

Starting date: October 2010
Last updated: February 6, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017